"Explaining the utility of the tool, he noted, If patients know what to expect, they may want their physicians to consider less costly medications. "
New York, June 22 - Along with distress that comes with cancer diagnosis and the discomfort of treatment, more patients now have to deal with financial toxicity, the expense, anxiety and loss of confidence confronting those who face large, unpredictable costs.

Researchers have now developed a tool to measure a patient's risk for, and ability to tolerate, financial stress that comes with cancer.

Named COST (Comprehensive Score for financial Toxicity), the tool comprises 11 questions, assembled and refined from conversations with more than 150 patients with advanced cancer.

A few physicians discuss this increasingly significant side effect with their patients, said Jonas de Souza, head-and-neck cancer specialist at University of Chicago Department of Medicine in the US.

We believe that a thoughtful, concise tool that could help predict a patient's risk for financial toxicity might open the lines of communication. This gives us a way to launch that discussion, de Souza added.

Explaining the utility of the tool, he noted, If patients know what to expect, they may want their physicians to consider less costly medications.

The findings appeared in the journal Cancer.


comments powered by Disqus
Read more on:
 ANXIETY (2281 views)
 

PERMALINK

http://www.nerve.in/news:2535002383019
You can quote the permanent link above for a direct link to the story. We do not archive or expire our news stories.


STORY OPTIONS
  Email this story to a friend
  XML feed for Americas


 
COPYRIGHTS INFORMATION
All rights reserved for news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.
Contact Nerve Staff for any feedback, corrections and omissions in news stories.
 

All rights reserved for the news content. Reproduction, storage or redistribution of Nerve content and articles in any medium is strictly prohibited.